1.
Bioorg Med Chem Lett
; 13(19): 3185-90, 2003 Oct 06.
Article
in English
| MEDLINE
| ID: mdl-12951090
ABSTRACT
A new class of O-arylmandelic acid PPAR agonists show excellent anti-hyperglycemic efficacy in a db/db mouse model of DM2. These PPARalpha-weighted agonists do not show the typical PPARgamma associated side effects of BAT proliferation and cardiac hypertrophy in a rat tolerability assay.